Bayer Aktiengesellschaft (BUD:BAYER)
Hungary · Delayed Price · Currency is HUF | Market Cap | 13.62T +62.3% |
| Revenue (ttm) | 17.51T -2.2% |
| Net Income | -1,390.58B |
| EPS | -1,415.46 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 8.96 |
| Dividend | 40.15 (0.29%) |
| Ex-Dividend Date | Apr 27, 2026 |
| Volume | 9 |
| Average Volume | 212 |
| Open | 13,695 |
| Previous Close | 13,310 |
| Day's Range | 13,695 - 13,695 |
| 52-Week Range | 8,988 - 18,700 |
| Beta | n/a |
| RSI | 36.40 |
| Earnings Date | May 12, 2026 |
About Bayer Aktiengesellschaft
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and ge... [Read more]
Financial Performance
In 2025, Bayer Aktiengesellschaft's revenue was 45.58 billion, a decrease of -2.21% compared to the previous year's 46.61 billion. Losses were -3.62 billion, 41.8% more than in 2024.
Financial numbers in EUR Financial StatementsNews
House strips MAHA-hated pesticide provisions from farm bill
MAHA advocates said the language that was stripped could have provided liability protection for Bayer in lawsuits involving its Roundup weedkiller.
Bayer to Present 13 Abstracts From Its Stroke Franchise at ESOC 2026, Including Two Late-breaking Analyses From the Phase III OCEANIC-STROKE Trial of Asundexian
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced that a broad set of data from its stroke franchise will be presented at the 2026 European Stroke Organisation Conference (ESOC), including new la...
New Study Highlights Societal Optimism Toward Breakthrough Science, and Rising Anxiety About How Fast the World Is Changing
BERLIN--(BUSINESS WIRE)--A new study from Leaps by Bayer and BCG reveals varying trends in how the public views breakthrough science in China, Germany, and the United States.
Trump draws criticism from MAHA base over weed killer glyphosate
The Supreme Court is considering arguments around the broadly used herbicide glyphosate, which is sold by Bayer subsidiary Monsanto as "Roundup." The case will determine whether state laws preempt fed...
Bayer Faces Critical Supreme Court Debate Over Roundup Lawsuits
Bayer Faces Critical Supreme Court Debate Over Roundup Lawsuits
Bayer Faces Supreme Court Challenges Over Roundup Lawsuits (BAYRY)
Bayer Faces Supreme Court Challenges Over Roundup Lawsuits (BAYRY)
Bayer Stock Plunges As Supreme Court Wrestles With Roundup Cancer Suits
Bayer AG (OTC: BAYRY) shares took a steep dive late Monday afternoon as the U.S. Supreme Court grappled with whether to shield the chemical giant from tens of thousands of cancer lawsuits involving i...
Bayer shares slide after U.S. Supreme Court split over Bayer's fight against Roundup lawsuits
Shares in chemicals giant Bayer fell as much as 6.5% on Tuesday after the U.S. Supreme Court appeared split over what view it will form in Bayer's fight against Roundup lawsuits.
Bayer Faces Legal Challenge Over Roundup Liability
Bayer Faces Legal Challenge Over Roundup Liability
With Bayer at US Supreme Court, MAHA rallies against pesticides
"Make America Healthy Again" activists rallied at the U.S. Supreme Court building on Monday against Bayer as the justices heard arguments in the German company's effort to end thousands of lawsuits t...
Bayer Faces Supreme Court Hearing on Roundup Liability
Bayer Faces Supreme Court Hearing on Roundup Liability
US Supreme Court hears Bayer's fight against Roundup lawsuits
The U.S. Supreme Court is set on Monday to consider Bayer AG's effort to shut down thousands of lawsuits accusing the company of failing to warn users that the active ingredient in its Roundup weedki...
Bayer (BAYRY) Faces Supreme Court Hearings on Roundup Lawsuits
Bayer (BAYRY) Faces Supreme Court Hearings on Roundup Lawsuits
Explainer: What does Bayer's US Supreme Court case mean for the thousands of Roundup lawsuits?
The U.S. Supreme Court hears arguments on Monday in Bayer's bid to limit thousands of lawsuits alleging that the German company's Roundup weedkiller causes cancer in a case that is one part of sprawli...
Bayer Advances $7.25 Billion Roundup Settlement Ahead of Key Supreme Court Ruling
Bayer Advances $7.25 Billion Roundup Settlement Ahead of Key Supreme Court Ruling
Buy or Goodbye?: Alphabet, Nestle, Bayer und SAP - Die Analystenstimmen des Tages
Alphabet, Nestle, Bayer und SAP: Die wichtigsten Analysten-Updates im Überblick.
Bayer Aktiengesellschaft Transcript: AGM 2026
The meeting highlighted strong financial performance, progress on debt reduction, and strategic transformation, while addressing ongoing litigation risks and shareholder concerns on ESG and governance. All management proposals, including a minimum dividend and new board appointments, were approved by large majorities.
Bayer (BAYRY) Faces Crucial $7.5 Billion Settlement Decision in Roundup Litigation
Bayer (BAYRY) Faces Crucial $7.5 Billion Settlement Decision in Roundup Litigation
The Cancer Victims Who Could Sink Bayer's Roundup Settlement
With thousands of cases piling up in U.S. courts, the company's relief plans still face hurdles.
US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims
A U.S. judge has rejected Bayer's request for an injunction to block Johnson & Johnson's alleged false advertising that its multibillion-dollar drug cuts the risk of death from prostate cancer in hal...
Bayer's Lawsuit Against Johnson & Johnson Over Prostate Cancer Drug Advertising Dismissed
Bayer's Lawsuit Against Johnson & Johnson Over Prostate Cancer Drug Advertising Dismissed
U.S. judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims
A U.S. judge has rejected Bayer’s request for an injunction to block Johnson & Johnson’s alleged false advertising that its multibillion-dollar drug cuts the risk of death from prostate cancer in half...
U.S. judge rejects Bayer's bid to block Johnson & Johnson prostate cancer drug claims
A federal judge rejected Bayer's request for an injunction to block Johnson & Johnson's alleged false advertising that its multibillion-dollar drug cuts the risk of death from prostate cancer i...
Bayer Canada Supports New School of Medicine at Simon Fraser University (SFU) With Full Tuition Entrance Award for Inaugural Class
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Bayer Canada is proud to support the Simon Fraser University (SFU) School of Medicine - the first medical school in Western Canada in nearly 60 years. The new sc...
Bayer US head says tariffs will not affect its 2026 forecasts
A top Bayer AG executive said on Tuesday the German drugmaking and crop science company saw no need to adjust its 2026 forecasts because of tariffs on imported pharmaceuticals announced by the U.S. ...